Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:06:17 UTC |
---|
Update Date | 2021-09-14 15:25:43 UTC |
---|
HMDB ID | HMDB0060903 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Reduced haloperidol |
---|
Description | Reduced haloperidol belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Reduced haloperidol is a very strong basic compound (based on its pKa). Reduced haloperidol is a metabolite of haloperidol. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. Haloperidol is a typical antipsychotic. |
---|
Structure | OC(CCCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)C1=CC=C(F)C=C1 InChI=1S/C21H25ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,20,25-26H,1-2,11-15H2 |
---|
Synonyms | Value | Source |
---|
4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol | HMDB | Reduced haloperidol | MeSH | Hydroxyhaloperidol | MeSH |
|
---|
Chemical Formula | C21H25ClFNO2 |
---|
Average Molecular Weight | 377.88 |
---|
Monoisotopic Molecular Weight | 377.155784961 |
---|
IUPAC Name | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol |
---|
Traditional Name | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(CCCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)C1=CC=C(F)C=C1 |
---|
InChI Identifier | InChI=1S/C21H25ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,20,25-26H,1-2,11-15H2 |
---|
InChI Key | WNZBBTJFOIOEMP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Piperidines |
---|
Sub Class | Phenylpiperidines |
---|
Direct Parent | Phenylpiperidines |
---|
Alternative Parents | |
---|
Substituents | - Phenylpiperidine
- Phenylbutylamine
- Aralkylamine
- Chlorobenzene
- Fluorobenzene
- Halobenzene
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Tertiary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Secondary alcohol
- Azacycle
- Alcohol
- Organofluoride
- Organochloride
- Organohalogen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic alcohol
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Reduced haloperidol,1TMS,isomer #1 | C[Si](C)(C)OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 2861.8 | Semi standard non polar | 33892256 | Reduced haloperidol,1TMS,isomer #2 | C[Si](C)(C)OC1(C2=CC=C(Cl)C=C2)CCN(CCCC(O)C2=CC=C(F)C=C2)CC1 | 2926.7 | Semi standard non polar | 33892256 | Reduced haloperidol,2TMS,isomer #1 | C[Si](C)(C)OC(CCCN1CCC(O[Si](C)(C)C)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 2846.1 | Semi standard non polar | 33892256 | Reduced haloperidol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 3090.8 | Semi standard non polar | 33892256 | Reduced haloperidol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1(C2=CC=C(Cl)C=C2)CCN(CCCC(O)C2=CC=C(F)C=C2)CC1 | 3161.2 | Semi standard non polar | 33892256 | Reduced haloperidol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CCCN1CCC(O[Si](C)(C)C(C)(C)C)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 3321.6 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Reduced haloperidol GC-MS (Non-derivatized) - 70eV, Positive | splash10-076r-4955000000-d4605ccb0a63e273e150 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Reduced haloperidol GC-MS (2 TMS) - 70eV, Positive | splash10-0a5a-9670880000-f526e688452b80393c6f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Reduced haloperidol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Positive-QTOF | splash10-03fr-0009000000-34094c22bd48e50c75c6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Positive-QTOF | splash10-03fu-0549000000-954ad12bf6275132b8f5 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Positive-QTOF | splash10-0006-4972000000-a14fb311dc8f6dd4fea6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Negative-QTOF | splash10-004i-0009000000-abde1d76fafd8040c105 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Negative-QTOF | splash10-056r-1239000000-86643aa86096d4ed639f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Negative-QTOF | splash10-01ot-6930000000-fde008bb1ea71c615c20 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Positive-QTOF | splash10-004i-0009000000-7e459a6c473b027b7520 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Positive-QTOF | splash10-03fr-0019000000-5583edfd6fd7733bf350 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Positive-QTOF | splash10-0002-1901000000-d9271b2da3486c477293 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Negative-QTOF | splash10-004i-0009000000-46f26e7fc44cc92362d0 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Negative-QTOF | splash10-004i-2109000000-1c473b3289a0c30ea73a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Negative-QTOF | splash10-0089-8019000000-9258ff517e784322afba | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|